|
US6465427B1
(en)
*
|
1996-07-12 |
2002-10-15 |
Mcgill University |
Compounds and methods for modulating cell adhesion
|
|
US6562786B1
(en)
|
1996-07-12 |
2003-05-13 |
Mcgill University |
Compounds and methods for modulating apoptosis
|
|
US6207639B1
(en)
*
|
1996-07-12 |
2001-03-27 |
Mcgill University |
Compounds and methods for modulating neurite outgrowth
|
|
US20040006011A1
(en)
*
|
1996-07-12 |
2004-01-08 |
Gour Barbara J. |
Peptidomimetic modulators of cell adhesion
|
|
US7122623B2
(en)
*
|
1996-07-12 |
2006-10-17 |
Adherex Technologies, Inc. |
Compounds and methods for modulating cell adhesion
|
|
US6346512B1
(en)
*
|
1996-07-12 |
2002-02-12 |
Mcgill University |
Compounds and methods for modulating cell adhesion
|
|
US6333307B1
(en)
*
|
1996-07-12 |
2001-12-25 |
Mcgill University |
Compounds and method for modulating neurite outgrowth
|
|
US6610821B1
(en)
*
|
1996-07-12 |
2003-08-26 |
Mcgill University |
Compounds and methods for modulating endothelial cell adhesion
|
|
US6417325B1
(en)
*
|
1996-07-12 |
2002-07-09 |
Mcgill University |
Compounds and methods for cancer therapy
|
|
US6169071B1
(en)
*
|
1996-07-12 |
2001-01-02 |
Mcgill University |
Compounds and methods for modulating cell adhesion
|
|
WO1998002452A2
(en)
|
1996-07-12 |
1998-01-22 |
Mcgill University |
Compounds and methods for modulating cell adhesion
|
|
US6551994B1
(en)
|
1997-04-10 |
2003-04-22 |
Mcgill University |
Compounds and methods for inhibiting the interaction between α-catenin and β-catenin
|
|
US6638911B1
(en)
|
1998-05-05 |
2003-10-28 |
Adherex Technologies Inc. |
Compounds and methods for modulating desmosomal cadherin-mediated functions
|
|
US7481999B2
(en)
*
|
1998-05-05 |
2009-01-27 |
Adherex Technologies, Inc. |
Compounds and methods for modulating OB-cadherin-mediated function
|
|
US6680175B2
(en)
*
|
1998-05-05 |
2004-01-20 |
Adherex Technologies, Inc. |
Methods for diagnosing and evaluating cancer
|
|
WO1999057149A2
(en)
*
|
1998-05-05 |
1999-11-11 |
Adherex Technologies, Inc. |
Compounds and methods for modulating nonclassical cadherin-mediated functions
|
|
US6472367B1
(en)
*
|
1998-05-05 |
2002-10-29 |
Adherex Technologies, Inc. |
Compounds and methods for modulating OB-cadherin mediated cell adhesion
|
|
US20050203025A1
(en)
*
|
1998-05-05 |
2005-09-15 |
Adherex Technologies, Inc. |
Compounds and methods for modulating nonclassical cadherin-mediated functions
|
|
EP1091762A1
(en)
|
1998-07-02 |
2001-04-18 |
Genzyme Corporation |
Transgene expression in polarized cells
|
|
US6277824B1
(en)
*
|
1998-07-10 |
2001-08-21 |
Adherex Technologies |
Compounds and methods for modulating adhesion molecule function
|
|
WO2000062815A2
(en)
*
|
1999-04-15 |
2000-10-26 |
Glaxo Group Limited |
Novel pharmaceutical composition suitable for gene therapy
|
|
US6303576B1
(en)
*
|
1999-04-21 |
2001-10-16 |
Adherex Technologies Inc. |
Compounds and methods for modulating β-catenin mediated gene expression
|
|
US20040254099A1
(en)
*
|
1999-04-21 |
2004-12-16 |
Adherex Technologies, Inc. |
Compounds and methods for modulating beta-catenin mediated gene expression
|
|
US6391855B1
(en)
*
|
1999-06-02 |
2002-05-21 |
Adherex Technologies, Inc. |
Compounds and methods for modulating junctional adhesion molecule-mediated functions
|
|
US6787136B1
(en)
|
1999-09-03 |
2004-09-07 |
The Brigham And Women's Hospital, Inc. |
Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
|
|
AU2001231154A1
(en)
*
|
2000-01-24 |
2001-07-31 |
Adherex Technologies Inc. |
Peptidomimetic modulators of cell adhesion
|
|
WO2002034880A2
(en)
*
|
2000-10-23 |
2002-05-02 |
University Of Kansas |
Cadherin peptides for drug delivery and inhibition of tumor metastasis/invasion
|
|
US6815426B2
(en)
*
|
2001-02-16 |
2004-11-09 |
E. I. Du Pont De Nemours And Company |
Angiogenesis-inhibitory tripeptides, compositions and their methods of use
|
|
US20020192206A1
(en)
*
|
2001-05-05 |
2002-12-19 |
Kozarov Emil V. |
Methods and compositions for angioproliferative disorder treatment
|
|
US20030105025A1
(en)
*
|
2001-10-31 |
2003-06-05 |
Fortuna Haviv |
Tri-and tetrapeptides having antiangiogenic activity
|
|
US7175990B2
(en)
*
|
2002-02-26 |
2007-02-13 |
The Regents Of The University Of California |
Method of determining endometrial receptivity
|
|
AU2003283155A1
(en)
*
|
2002-11-14 |
2004-06-03 |
Adherex Technologies Inc. |
Compounds and methods for modulating functions of classical cadherins
|
|
WO2004048411A2
(en)
*
|
2002-11-14 |
2004-06-10 |
Adherex Technologies, Inc. |
Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion
|
|
US7196061B2
(en)
|
2003-09-10 |
2007-03-27 |
Wyeth |
Compounds that modulate neuronal growth and their uses
|
|
JP4800216B2
(ja)
*
|
2003-10-24 |
2011-10-26 |
エグゼリクシス， インコーポレイテッド |
ｐ７０Ｓ６キナーゼモジュレーターおよび使用方法
|
|
CN1933832A
(zh)
*
|
2004-03-08 |
2007-03-21 |
惠氏公司 |
离子通道调节剂
|
|
US7169756B2
(en)
*
|
2004-04-16 |
2007-01-30 |
Mcmaster University |
Streptogramin antibiotics
|
|
KR100990027B1
(ko)
|
2005-04-26 |
2010-10-26 |
화이자 인코포레이티드 |
Ｐ-카드헤린 항체
|
|
US7691839B2
(en)
|
2005-09-28 |
2010-04-06 |
Biovascular, Inc. |
Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
|
|
US20110034396A1
(en)
*
|
2005-09-28 |
2011-02-10 |
Biovascular, Inc. |
Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
|
|
JP2009538282A
(ja)
*
|
2006-05-15 |
2009-11-05 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
乏突起膠細胞の生存を促進させるためのＮｏｇｏ受容体−１（ＮｇＲ１）アンタゴニストの使用
|
|
US20080194467A1
(en)
*
|
2006-09-27 |
2008-08-14 |
Adherex Technologies, Inc. |
Cancer treatment methods using cadherin antagonists in combination with anticancer agents
|
|
CA2669696A1
(en)
|
2006-11-15 |
2008-05-22 |
Dana-Farber Cancer Institute, Inc. |
Stabilized maml peptides and uses thereof
|
|
US20090291967A1
(en)
*
|
2008-03-05 |
2009-11-26 |
Adherex Technologies, Inc. |
Small molecule modulators of cell adhesion
|
|
US9599603B2
(en)
*
|
2008-07-16 |
2017-03-21 |
Case Western Reserve University |
Methods and compositions for modulating adhesion and migration of cadherin expressing cells
|
|
EP2376100B1
(en)
|
2009-01-14 |
2017-10-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US8680150B2
(en)
|
2009-05-28 |
2014-03-25 |
Ligand Pharmaceuticals, Inc. |
Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors
|
|
CA2774973A1
(en)
*
|
2009-09-22 |
2011-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US8877188B2
(en)
|
2010-05-04 |
2014-11-04 |
The Brigham And Women's Hospital, Inc. |
Detection and treatment of non-dermal fibrosis
|
|
FR2980741B1
(fr)
|
2011-09-30 |
2014-03-14 |
Saint Gobain |
Procede d'assemblage par collage d'un vitrage sur un support avec interposition d'une cale d'ecartement, vitrage muni d'une cale d'ecartement, cale, cordon profile et ensemble de cales.
|
|
US8633158B1
(en)
|
2012-10-02 |
2014-01-21 |
Tarix Pharmaceuticals Ltd. |
Angiotensin in treating brain conditions
|
|
CN105451756A
(zh)
|
2013-05-24 |
2016-03-30 |
塔瑞克斯制药有限公司 |
在治疗马凡氏综合征及其相关病症中的血管紧张素肽
|
|
JP2017501967A
(ja)
|
2013-10-11 |
2017-01-19 |
タリックス ファーマシューティカルズ リミテッド |
新規なペプチド組成物
|
|
US9133241B2
(en)
|
2013-10-11 |
2015-09-15 |
Tarix Pharmaceuticals Ltd. |
Peptide compositions
|
|
EP3074417A4
(en)
|
2013-11-25 |
2017-05-03 |
Unm.Stc |
Cxcr antagonistic peptides and uses thereof
|
|
US9333233B2
(en)
|
2014-02-25 |
2016-05-10 |
Tarix Pharmaceuticals Ltd. |
Methods and compositions for the delayed treatment of stroke
|
|
JP2017520575A
(ja)
|
2014-07-01 |
2017-07-27 |
ファイザー・インク |
二重特異的ヘテロ二量体ダイアボディおよびその使用
|
|
WO2016100301A1
(en)
|
2014-12-15 |
2016-06-23 |
The Brigham And Women's Hospital, Inc. |
Use of cadherin-11 antagonists to treat obesity-associated conditions and other metabolic disorders
|
|
WO2016097753A1
(en)
*
|
2014-12-19 |
2016-06-23 |
Neuro-Bio Ltd |
Cyclic acetylcholinesterase c-terminal peptide in the treatment or prevention of cancer or metastasis
|
|
GB2538947A
(en)
*
|
2014-12-19 |
2016-12-07 |
Neuro-Bio Ltd |
Cancer
|
|
WO2017004548A1
(en)
|
2015-07-01 |
2017-01-05 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
EP3373951B1
(en)
|
2015-10-14 |
2021-11-17 |
Tarix Pharmaceuticals Ltd. |
Methods and compositions for the treatment of epidermolysis bullosa
|
|
KR102167755B1
(ko)
*
|
2018-05-23 |
2020-10-19 |
주식회사 큐어바이오 |
단편화된 grs 폴리펩타이드, 이의 변이체 및 이들의 용도
|
|
US20220227815A1
(en)
*
|
2019-06-21 |
2022-07-21 |
University Of Kansas |
Compositions and methods useful in treating brain diseases
|
|
US20230110554A1
(en)
|
2020-03-13 |
2023-04-13 |
Constant Therapeutics Llc |
Methods and compositions for treatment of coronavirus infection
|
|
WO2022098051A1
(ko)
*
|
2020-11-05 |
2022-05-12 |
한국생명공학연구원 |
항염 및 조직 재생작용을 갖는 신규 펩타이드
|
|
CN116535406B
(zh)
*
|
2022-01-25 |
2025-06-24 |
中国科学院大连化学物理研究所 |
一种多萜衍生物的对映选择性合成方法及多萜衍生物
|
|
CN116535281B
(zh)
*
|
2022-01-25 |
2025-06-24 |
中国科学院大连化学物理研究所 |
一种手性环状单萜衍生物及其合成方法
|
|
TW202539635A
(zh)
|
2023-12-04 |
2025-10-16 |
美商康斯坦特治療有限責任公司 |
用於治療天疱瘡或類天疱瘡疾病的經改良方法及組成物
|
|
WO2025137668A1
(en)
|
2023-12-21 |
2025-06-26 |
Constant Therapeutics, Llc |
Methods and compositions for the treatment of optic neuropathy
|